enkephalin, leucine has been researched along with Arteriosclerosis Obliterans in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Didenko, VA; Dudko, VA; Fedorova, NA; Zoloev, GK | 1 |
Argintaev, ES; Prum, IA; Slepushkin, VD; Sokolovich, GE; Zoloev, GK | 1 |
1 trial(s) available for enkephalin, leucine and Arteriosclerosis Obliterans
Article | Year |
---|---|
[Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
Topics: Adult; Arteriosclerosis Obliterans; Clinical Trials as Topic; Drug Evaluation; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Leg; Middle Aged; Placebos; Sympatholytics | 1990 |
1 other study(ies) available for enkephalin, leucine and Arteriosclerosis Obliterans
Article | Year |
---|---|
[Use of synthetic analogs of enkephalins as antiatherogenic means].
Topics: Adult; Animals; Arteriosclerosis Obliterans; Cholesterol; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Humans; Lactates; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Parathyroid Hormone; Rats; Rats, Inbred Strains; Sympatholytics | 1989 |